Emergency management of status epilepticus in a high-fidelity simulation: A prospective study.


Journal

Neurology
ISSN: 1526-632X
Titre abrégé: Neurology
Pays: United States
ID NLM: 0401060

Informations de publication

Date de publication:
05 11 2019
Historique:
received: 08 04 2019
accepted: 19 08 2019
pubmed: 9 10 2019
medline: 6 2 2020
entrez: 10 10 2019
Statut: ppublish

Résumé

To quantify the quality of physicians' emergency first response to status epilepticus (SE) and to identify risk factors for nonadherence to treatment guidelines in a standardized simulated scenario. In this prospective trial, 58 physicians (of different background) of the University Hospital Basel, a Swiss academic medical care center, were confronted with a simulated SE. Primary outcomes were time to (1) airway protection, (2) supplementary oxygen, and (3) administration of antiseizure drugs (ASDs). All physicians recognized ongoing seizures. Airways were checked by 54% and protected by 16% within a median of 3.9 minutes. Supplementary oxygen was administered by 76% with a median of 2.8 minutes. First-line ASDs were administered by 98% (benzodiazepines 97% within a median of 2.9 minutes), and second-line ASDs by 57% within 8.1 minutes. Regarding secondary outcomes, the median time to monitor blood pressure and heart rate was 1.8 (interquartile range [IQR] 1.3-2.6) and 2.0 (IQR 1.4-2.7) minutes, respectively. Neurologic affiliation of physicians was associated with inadequate assessments of vital signs (odds ratio [OR] = 0.2; 95% CI 0.04-0.93) and most frequent administration of second-line ASDs (OR = 5.0; 95% CI 1.01-25.3). Knowing treatment guidelines and subjective certainty regarding SE diagnosis were associated with frequent administration of second-line ASDs (OR = 10.4; 95% CI 1.2-88.1). Nonadherence to SE treatment guidelines is frequent. The lack of airway assessment and protection in the simulated clinical scenario of SE may increase mortality and promote treatment refractoriness related to aspiration pneumonia. Guideline-based clinical training is urgently needed to increase the quality of SE management. ISRCTN registry (ID ISRCTN60369617; www.isrctn.com/ISRCTN60369617).

Identifiants

pubmed: 31594860
pii: WNL.0000000000008461
doi: 10.1212/WNL.0000000000008461
doi:

Substances chimiques

Anticonvulsants 0
Benzodiazepines 12794-10-4

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

838-848

Informations de copyright

© 2019 American Academy of Neurology.

Auteurs

Raoul Sutter (R)

From the Clinic for Intensive Care Medicine (R.S., K.T., P.O., S.M.), University Hospital Basel; Department of Neurology (R.S., G.M.D.M.), University Hospital Basel; Medical Faculty (R.S., G.M.D.M., S.B., R.B., S.H., S.M.), University of Basel; Division of Internal Medicine (P.O., S.B.), University Hospital Basel; Department of Emergency Medicine (R.B.), University Hospital Basel; and Department of Psychosomatic Medicine (S.H.), University Hospital Basel, Switzerland. Raoul.Sutter@usb.ch.

Kai Tisljar (K)

From the Clinic for Intensive Care Medicine (R.S., K.T., P.O., S.M.), University Hospital Basel; Department of Neurology (R.S., G.M.D.M.), University Hospital Basel; Medical Faculty (R.S., G.M.D.M., S.B., R.B., S.H., S.M.), University of Basel; Division of Internal Medicine (P.O., S.B.), University Hospital Basel; Department of Emergency Medicine (R.B.), University Hospital Basel; and Department of Psychosomatic Medicine (S.H.), University Hospital Basel, Switzerland.

Petra Opić (P)

From the Clinic for Intensive Care Medicine (R.S., K.T., P.O., S.M.), University Hospital Basel; Department of Neurology (R.S., G.M.D.M.), University Hospital Basel; Medical Faculty (R.S., G.M.D.M., S.B., R.B., S.H., S.M.), University of Basel; Division of Internal Medicine (P.O., S.B.), University Hospital Basel; Department of Emergency Medicine (R.B.), University Hospital Basel; and Department of Psychosomatic Medicine (S.H.), University Hospital Basel, Switzerland.

Gian Marco De Marchis (GM)

From the Clinic for Intensive Care Medicine (R.S., K.T., P.O., S.M.), University Hospital Basel; Department of Neurology (R.S., G.M.D.M.), University Hospital Basel; Medical Faculty (R.S., G.M.D.M., S.B., R.B., S.H., S.M.), University of Basel; Division of Internal Medicine (P.O., S.B.), University Hospital Basel; Department of Emergency Medicine (R.B.), University Hospital Basel; and Department of Psychosomatic Medicine (S.H.), University Hospital Basel, Switzerland.

Stefano Bassetti (S)

From the Clinic for Intensive Care Medicine (R.S., K.T., P.O., S.M.), University Hospital Basel; Department of Neurology (R.S., G.M.D.M.), University Hospital Basel; Medical Faculty (R.S., G.M.D.M., S.B., R.B., S.H., S.M.), University of Basel; Division of Internal Medicine (P.O., S.B.), University Hospital Basel; Department of Emergency Medicine (R.B.), University Hospital Basel; and Department of Psychosomatic Medicine (S.H.), University Hospital Basel, Switzerland.

Roland Bingisser (R)

From the Clinic for Intensive Care Medicine (R.S., K.T., P.O., S.M.), University Hospital Basel; Department of Neurology (R.S., G.M.D.M.), University Hospital Basel; Medical Faculty (R.S., G.M.D.M., S.B., R.B., S.H., S.M.), University of Basel; Division of Internal Medicine (P.O., S.B.), University Hospital Basel; Department of Emergency Medicine (R.B.), University Hospital Basel; and Department of Psychosomatic Medicine (S.H.), University Hospital Basel, Switzerland.

Sabina Hunziker (S)

From the Clinic for Intensive Care Medicine (R.S., K.T., P.O., S.M.), University Hospital Basel; Department of Neurology (R.S., G.M.D.M.), University Hospital Basel; Medical Faculty (R.S., G.M.D.M., S.B., R.B., S.H., S.M.), University of Basel; Division of Internal Medicine (P.O., S.B.), University Hospital Basel; Department of Emergency Medicine (R.B.), University Hospital Basel; and Department of Psychosomatic Medicine (S.H.), University Hospital Basel, Switzerland.

Stephan Marsch (S)

From the Clinic for Intensive Care Medicine (R.S., K.T., P.O., S.M.), University Hospital Basel; Department of Neurology (R.S., G.M.D.M.), University Hospital Basel; Medical Faculty (R.S., G.M.D.M., S.B., R.B., S.H., S.M.), University of Basel; Division of Internal Medicine (P.O., S.B.), University Hospital Basel; Department of Emergency Medicine (R.B.), University Hospital Basel; and Department of Psychosomatic Medicine (S.H.), University Hospital Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH